Closing Bell: Fennec Pharmaceuticals Inc down on Monday (FRX)

In today's trading, shares of Fennec Pharmaceuticals Inc opened at $9.25 and closed at $8.76. It traded at a low of $8.76 to a high of $9.25.

The price eased -5.09 percent from the previous day's close of $9.23.

During the day across North America, the TSX Composite closed -0.15% at 22779.57, the S&P 500 closed 1.11% at 5459.10, the Dow Jones Industrial Average closed 1.64% at 40589.34 and the Nasdaq Composite closed 1.03% at 17357.88.

Fennec Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker FRX.

A total of 307 shares was traded during the session, with total trades of 5. On average, Fennec Pharmaceuticals Inc has traded 1,127 shares over 5 days and 1,767 year-to-date.

Trading across the entire TSX saw 1,903 price advancers against 3,356 declines and 91 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, the shares have reduced -22.27% in the last 52 weeks, while in 2024, they have shrunken -42.22%.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $252.18 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Research Triangle Park, USA.

Currently, Fennec Pharmaceuticals Inc's consensus rating is "Strong Buy" based on 6 analysts according to Zacks. From those 6 analysts, 6 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..